| Literature DB >> 12209149 |
Emanuel F Petricoin1, Kathryn C Zoon, Elise C Kohn, J Carl Barrett, Lance A Liotta.
Abstract
The ultimate goal of proteomics is to characterize the information flow through protein networks. This information can be a cause, or a consequence, of disease processes. Clinical proteomics is an exciting new subdiscipline of proteomics that involves the application of proteomic technologies at the bedside, and cancer, in particular, is a model disease for studying such applications. Here, we describe proteomic technologies that are being developed to detect cancer earlier, to discover the next generation of targets and imaging biomarkers, and finally to tailor the therapy to the patient.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12209149 DOI： 10.1038/nrd891
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694